Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. HeartSciences's pretax income for the
three
months ended in Apr. 2026 was $-2.75 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Apr. 2026 was $-9.14 Mil.
HeartSciences's pretax margin was %.
During the past 7 years, HeartSciences's highest Pretax Margin was -5954.69%. The lowest was -228550.00%. And the median was -34763.16%.
During the past 7 years, HeartSciences's highest Pretax Margin was -5954.69%. The lowest was -228550.00%. And the median was -34763.16%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartSciences Pre-Tax Income Related Terms
HeartSciences Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for HeartSciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSCS vs IRIX, ALRTF, ADGM: Pre-Tax Income Comparison
For the Medical Devices subindustry, HeartSciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartSciences Pre-Tax Income vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where HeartSciences's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartSciences (HSCS) has a Pre-Tax Income of $-9.14 Mil as of Apr. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on HeartSciences and its competitors.
Is HeartSciences' Pre-Tax Income too high?
HeartSciences' current Pre-Tax Income is $-9.14 Mil. Overall, HeartSciences has a GF Score™ of 18/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Pre-Tax Income compare to IRIX and ALRTF?
HeartSciences' Pre-Tax Income of $-9.14 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Medical Devices & Instruments company?
A good Pre-Tax Income depends on the Medical Devices & Instruments industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on HeartSciences and its competitors. HeartSciences's current Pre-Tax Income is $-9.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.54, compared to a current price of $4.12 — trading 663% above its estimated fair value. The current Pre-Tax Income is $-9.14 Mil. HeartSciences' overall GF Score™ is 18/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For HeartSciences (HSCS), the current Pre-Tax Income is $-9.14 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HeartSciences (HSCS) Overvalued in 2026?
Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued.
The current stock price of $4.12 is trading 663% above its estimated GF Value™ of $0.54.
GuruFocus considers HeartSciences to be Significantly Overvalued.
Key valuation signals for HSCS:
Pre-Tax Income: $-9.14 Mil
GF Value™: $0.54 vs. price of $4.12 (663% above fair value)
No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
18GF Score
Get the complete analysis for HSCS
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSCS has been successfully added to your 
